Not all individuals with CLL require therapy. Irrespective of all new innovations, the iwCLL even now recommends watchful observation for clients with asymptomatic condition.86 This advice relies on at the least two randomized trials evaluating observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 Both of those trials https://alexp097bks5.mappywiki.com/user